Cargando…
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
Malaria remains a major cause of morbidity and mortality in Africa, particularly in children under five years of age. Availability of effective anti-malarial drug treatment is a cornerstone for malaria control and eventual malaria elimination. Artemisinin-based combination therapy (ACT) is worldwide...
Autores principales: | Tindana, Paulina, de Haan, Freek, Amaratunga, Chanaki, Dhorda, Mehul, van der Pluijm, Rob W., Dondorp, Arjen M., Cheah, Phaik Yeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910789/ https://www.ncbi.nlm.nih.gov/pubmed/33639946 http://dx.doi.org/10.1186/s12936-021-03649-7 |
Ejemplares similares
-
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022) -
Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
por: Tindana, Paulina, et al.
Publicado: (2021) -
Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
por: de Haan, Freek, et al.
Publicado: (2022) -
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: de Haan, Freek, et al.
Publicado: (2021) -
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)